The European Union's press release distribution & newswire service ...

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

William T. Giles bought the dip in the bear and alcohol maker’s stock after Constellation reported a disappointing quarter.

PURCHASE, NY . — Rachel Ferdinando has been promoted from president of PepsiCo Foods Canada to chief executive officer of ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

Currys has raised profit guidance and pledged to resume dividend payments after the retailer reported a strong festive ...

British pharmaceutical company GSK on Monday said it had agreed to buy a US company that specialises in the treatment of rare gastrointestinal cancer GIST.

IDRx’s lead candidate IDRX-42 is being investigated in a Phase I/IIb trial in patients with advanced gastrointestinal stromal tumours.

GSK has announced a definitive agreement to acquire IDRx, a US-based biotechnology company specialising in treatments for gastrointestinal cancers, for up to $1.15bn in cash, marking the first ...

Sales of Apple's iPhone dipped in 2024, with the tech giant losing some of its market share last year, research indicated. Preliminary results from Counterpoint Research's market pulse showed that ...

GSK fired the opening gun for the 2025 JP Morgan Healthcare Conference on Monday with a front-loaded acquisition agreement, moving to buy precision therapy specialist IDRx and its rare cancer drug ...